{"version":"1.0","provider_name":"Canadian Drug Policy Coalition","provider_url":"https:\/\/www.drugpolicy.ca\/fr\/","author_name":"Donald MacPherson","author_url":"https:\/\/www.drugpolicy.ca\/fr\/author\/donaldm\/","title":"Drug policy should focus on harm reduction - Canadian Drug Policy Coalition","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"iyeN8zYIyp\"><a href=\"https:\/\/www.drugpolicy.ca\/fr\/3179\/\">Drug policy should focus on harm reduction<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.drugpolicy.ca\/fr\/3179\/embed\/#?secret=iyeN8zYIyp\" width=\"600\" height=\"338\" title=\"&#8220;Drug policy should focus on harm reduction&#8221; &#8212; Canadian Drug Policy Coalition\" data-secret=\"iyeN8zYIyp\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.drugpolicy.ca\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/van-cloud2-1960-1.ezp.net\/wp-content\/uploads\/2015\/11\/CDPC_KatrinaPaceyPivot_Blog_415x415px.jpg","thumbnail_width":415,"thumbnail_height":415,"description":"Katrina Pacey is the executive director of the Pivot Legal Society. Donald MacPherson is the executive director of the Canadian Drug Policy Coalition. The flurry of new initiatives introduced by the federal government signals a major philosophical shift on drug policy issues. First, Health Minister Jane Philpott approved the Dr. Peter Centre\u2019s application to continue [&hellip;]"}